Monday, September 28, 2015

A galactose-functionalized dendritic siRNA-nanovector to potentiate hepatitis C inhibition in liver cells

Nanoscale, 2015, Advance Article
DOI: 10.1039/C5NR02898A, Paper
Open Access Open Access
Abirami Lakshminarayanan, B. Uma Reddy, Nallani Raghav, Vijay Kumar Ravi, Anuj Kumar, Prabal K. Maiti, A. K. Sood, N. Jayaraman, Saumitra Das
A multidisciplinary approach providing 'proof-of-concept' for liver-targeted delivery of siRNA using dendritic galactoside vector to combat HCV infection.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry


Click for full article

No comments:

Post a Comment